Delegates 2008

• Guidelines
• Abstract form
• Conflict of interest

The IMCAS Scientific Programme Committee welcomes the submission of original contributions for poster and E-paper presentation at the Congress. Only abstracts not published elsewhere or submitted for presentation at another national meeting will be considered.

ABSTRACT DEADLINE - Sunday 15 June 2008
Abstracts received after this date will not be considered.

REGISTRATION AND PAYMENT
The presenting author must register for the congress and pay the registration fee upon acceptance of his/her abstract, otherwise the abstract will not be published.

ABSTRACT SUBMISSION
Carefully read the guidelines in this announcement before submitting your abstract. Acknowledgement of receipt of your submission will be returned to your email address immediately upon submission. If you do not receive the e-mail, your submission was not completed and your abstract needs to be re-submitted.

SUBMISSION GUIDELINES
Please observe that abstracts can only be submitted electronically. Abstracts must be written in English and the presentations must be in English. Accepted abstracts selected by expert reviewers will be presented in oral and poster sessions. Authors should indicate in the space provided the preferred method of presentation.

Posters will be displayed during the entire conference period and are accessible to all attendees at any time.
If your poster is accepted by the Scientific Committee, here are the requirements:

• present yourself at the Welcome Desk - Section FACULTY. Your hostess will bring you to the IMCAS POSTERS ROOM where your POSTER will be board posted
• the poster size could be up to : Width: 1,20 m / lenght: 1,50 m
• you are asked to be present by your poster during the poster session that always lasts 1 hour and occurs the last conference day, at lunch time.

Your presence during the conference is mandatory, otherwise the POSTER will be withdrawn.

E-PAPERS will be displayed at the IMCAS internet corners during the entire conference period and are accessible to all attendees at any time.
If your E-PAPER is accepted, here are the requirements:

• present yourself at the Welcome Desk - Section FACULTY. Your hostess will bring you to the IMCAS PREVIEW ROOM where your E-PAPER will be introduced within the central SERVER.
• bring a storage device (USB, CD, DVD) containing your E-PAPER or better, bring your laptop
• format: Powerpoint presentation (an average of 30-40 slides; duration: 20 min maximum)
• do not forget to attach all the files needed for your presentation (VIDEOS, pictures, etc..) otherwise, your POWERPOINT will not run properly.

Your presence during the conference is mandatory, otherwise the E-PAPER will not be introduced within our server.

In order to make the abstract as informative as possible, please include a brief statement of the purpose of the study, the method used, the result observed, and the conclusions based upon the results. It is inadequate to state “The results will be discussed” or “The data will be presented”. You may subtitle the paragraphs in bold format in the following order: Background, Method, Results, and Conclusion.

The abstract title and body text should only include pharmacopeia names printed in lower case. Trade names are not allowed. Non-proprietary (generic) names of drugs, written in lower case, are required at the first place a drug is mentioned. References, credits or the authors’ academic degrees or grant support must not be included in the abstract. Standard abbreviations may be employed in the text. Place special or unusual abbreviations in parentheses after the full wording at the first time it appears in the body of the text.

It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar, or scientific fact will be reproduced as typed by the author.

Please note that each year a number of abstracts are rejected because they contain no data or the English is unacceptable. Changes to abstracts can only be accepted until the deadline using the Personal Page.

TOPICS
One of the following topics that best describes the abstract should be indicated upon submission:

• MEDICAL TREATMENTS
  • FILLERS
  • BOTULINUM TOXIN
  • LASER
  • LIGHTS
• SURGICAL TREATMENTS
  • BODY SURGERY
  • FACE SURGERY
• OTHER
  • OFFICE MANAGEMENT
  • COSMECEUTICS

NOTIFICATION OF ACCEPTANCE
Notification of acceptance/rejection will be e-mailed within 10 days following the deadline. The corresponding author will receive all correspondence concerning the abstract.
The corresponding author is responsible for informing all authors of the status of the abstract.

“CONFLICT OF INTEREST STATEMENT” FORM 
The purpose of this Statement is to inform all interested parties of any significant affiliations or relationships you may have with any commercial enterprise. You must complete that form and email it back along with your abstract form.

PUBLICATION OF ABSTRACTS
Accepted abstracts will be published in the Abstract Book which will be given to all delegates attending the Congress upon registration. Accepted abstracts will also be published on a CD-ROM and/or on the Internet.

For submission support please contact the Congress Secretariat at: imcascongress@wanadoo.fr